- CANCER RESEARCH CAREER ENHANCEMENT AND RELATED ACTIVITIES Educating and training the next generation of leaders in cancer research is a key goal of the Wistar Cancer Center. As Wistar itself is not a degree-granting Institution, the educational mission of the Cancer Center focuses on dedicated partnerships with other institutions, matching the collaborative culture of inclusiveness and team science that are hallmarks of the Cancer Center. Evolved over the years, the educational mission of the Cancer Center is diverse in objectives and inter-institutional partnerships, running the gamut from a high school program in partnership with the School of District of Philadelphia, to an undergraduate Biomedical Technician Training (BTT) workforce development initiative in collaboration with the Community College of Philadelphia, to various graduate and post-graduate training mechanisms together with neighboring Universities. Support for Cancer Center educational activities comes mostly from peer-reviewed federal funding, currently totaling 10 awards for $1.34 million, including a long-running National Cancer Institute (NCI)- sponsored T32 training grant. During the last five years, significant investments were made to support an expansion of Cancer Center education, as codified in the 2015 Reimagining Wistar Strategic Plan. These included the recruitment of Brian Keith, Ph.D. as the new Associate Director for Education in the Cancer Center and the first-ever Dean of Biomedical Studies at Wistar, an expansive physical plant renovation to create dedicated classroom space and specific teaching laboratories, another ?first? for Wistar, and extensive online content development for the BTT program. Under the same inspiring criteria of inclusiveness, collaboration and inter-institutional partnership, the expansion of Wistar Cancer Center education during the next budget cycle of Wistar?s Cancer Center Support Grant (CCSG) will integrate the diverse educational activities at the Cancer Center in a coherent and synergistic platform; double the size of the BTT program to create a portable, scalable workforce development and job placement program in cancer research and the life sciences in partnership with the Commonwealth of Pennsylvania; expand a Ph.D.-granting program in cancer biology in collaboration with neighboring University of the Sciences (USciences), currently the only one in the greater Philadelphia region, to create a stable pipeline of postgraduate trainees in cancer research; and enrich the postdoctoral experience at the Cancer Center through a diversified portfolio of career and professional development tools. The planned collaborative expansion of Wistar education will fulfill a critical strategic goal of the Cancer Center in developing the cancer research workforce of the future.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA010815-50
Application #
9701526
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-03-01
Budget End
2020-02-29
Support Year
50
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Wistar Institute
Department
Type
DUNS #
075524595
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Papasavvas, Emmanouil; Lada, Steven M; Joseph, Jocelin et al. (2018) Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV. AIDS :
Duperret, Elizabeth K; Trautz, Aspen; Stoltz, Regina et al. (2018) Synthetic DNA-Encoded Monoclonal Antibody Delivery of Anti-CTLA-4 Antibodies Induces Tumor Shrinkage In Vivo. Cancer Res 78:6363-6370
Reyes-Uribe, Patricia; Adrianzen-Ruesta, Maria Paz; Deng, Zhong et al. (2018) Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma. Oncogene 37:4058-4072
Kugel 3rd, Curtis H; Douglass, Stephen M; Webster, Marie R et al. (2018) Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations. Clin Cancer Res 24:5347-5356
Fukumoto, Takeshi; Park, Pyoung Hwa; Wu, Shuai et al. (2018) Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer. Cell Rep 22:3393-3400
Bhattacharjee, Souvik; Coppens, Isabelle; Mbengue, Alassane et al. (2018) Remodeling of the malaria parasite and host human red cell by vesicle amplification that induces artemisinin resistance. Blood 131:1234-1247
Lu, Yunqi; Hu, Zhongyi; Mangala, Lingegowda S et al. (2018) MYC Targeted Long Noncoding RNA DANCR Promotes Cancer in Part by Reducing p21 Levels. Cancer Res 78:64-74
Thangavel, Chellappagounder; Boopathi, Ettickan; Liu, Yi et al. (2018) Therapeutic Challenge with a CDK 4/6 Inhibitor Induces an RB-Dependent SMAC-Mediated Apoptotic Response in Non-Small Cell Lung Cancer. Clin Cancer Res 24:1402-1414
Duperret, Elizabeth K; Liu, Shujing; Paik, Megan et al. (2018) A Designer Cross-reactive DNA Immunotherapeutic Vaccine that Targets Multiple MAGE-A Family Members Simultaneously for Cancer Therapy. Clin Cancer Res 24:6015-6027
Duperret, Elizabeth K; Wise, Megan C; Trautz, Aspen et al. (2018) Synergy of Immune Checkpoint Blockade with a Novel Synthetic Consensus DNA Vaccine Targeting TERT. Mol Ther 26:435-445

Showing the most recent 10 out of 741 publications